Building the future of
substance intelligence.
VeriChem is building analytical technologies, software, and data to help those protecting our communities better understand emerging drug threats and stay ahead of how they’re changing.
From discovery
to a safer tomorrow.
VeriChem began in a research laboratory at Harvard University, where our co-founders helped pioneer MagLev— a breakthrough in non-destructive separation technology.
What started as academic research quickly revealed real-world potential for law enforcement and forensic laboratories facing an evolving drug landscape.
Today, we’re turning that science into an integrated platform of devices, software, and data designed to deliver Substance Intelligence at scale.
Our goal is simple: give those on the front lines the tools and insights they need to stay ahead of threats and save lives.
Scientists. Innovators. Problem Solvers.
A multidisciplinary team combining science, business, and law enforcement experience to build better tools for understanding emerging drug threats.
Jay Letendre
Chief Executive Officer
Leads VeriChem’s strategy, commercialization, and growth, focused on turning breakthrough science into solutions for law enforcement and public safety.
Gary Macleod
Executive Chairman
Entrepreneur and business leader supporting VeriChem’s corporate strategy, financing, and long-term growth.
Christoffer Abrahamsson
Chief Science Officer
Scientist and co-inventor of VeriChem’s MagLev technology, leading the science behind the company’s separation and analytical platform.
Craig Fair
Chief Strategy Officer
Former FBI executive bringing decades of law-enforcement experience to VeriChem’s strategy, partnerships, and public-safety mission.
A safer tomorrow starts
with a deeper understanding of todays threats.
Our mission is to help those protecting our communities stay ahead of emerging drug threats.